Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 0 | 0 | 750 | 330 | 1,190 |
| Cost of Goods | N/A | 0 | 60 | 0 | 100 |
| Gross Profit | N/A | 0 | 680 | 330 | 1,080 |
| Operating Expenses | 36 | 50 | 490 | 670 | 1,270 |
| Operating Income | -36 | -50 | 260 | -340 | -80 |
| Interest Expense | 0 | 0 | 2 | 2 | 5 |
| Other Income | 0 | 0 | 542 | 2 | 5 |
| Pre-tax Income | -36 | -50 | 800 | -340 | -80 |
| Income Tax | -4 | 3 | 0 | 5 | -1 |
| Net Income Continuous | -32 | -53 | 800 | -345 | -79 |
| Net Income | $-32 | $-50 | $800 | $-350 | $-80 |
| EPS Basic Total Ops | -0.01 | -39,608.65 | 207,987.30 | -113,532.70 | -26,982.19 |
| EPS Basic Continuous Ops | -0.01 | -41,985.17 | 207,987.30 | -111,910.80 | -26,644.91 |
| EPS Diluted Total Ops | -0.01 | N/A | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -0.01 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-36 | $-50 | $260 | $-310 | $-40 |